The National Institutes of Health Office of the Director issued a $99,333 delivery order to Quantum Insights LLC on September 8, 2026, under the GSA Multiple Award Schedule (MAS) for enterprise platform services supporting the Strategic Plan Tracking and Reporting System (START). START serves as NIH's centralized enterprise platform for strategic plan tracking, performance monitoring, portfolio analysis, and reporting across all NIH institutes, centers, and offices. The GSA MAS is a...
<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for a QCI subscription valued at $24,000.00 on December 17, 2019, with ultimate completion on July 1, 2020. Place of performance is Germantown, Maryland. The order is firm fixed price with no set-aside applied.</p>
The National Cancer Institute issued a delivery order to Four Points Technology, L.L.C., a Service-Disabled Veteran-Owned Small Business, on July 21, 2026, in the amount of $118,076.83 for the Digital Science Dimensions for NIH Access Package. The order is issued under the Chief Information Officer Commodities and Solutions (CIO-CS) GWAC. Place of performance is Chantilly, VA. The ultimate completion date is November 20, 2026. This is a firm fixed price delivery order with no set-aside...
<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $5,549.00 on April 16, 2018, with final completion on May 12, 2018. No set-aside was used. The order covers software licensing—specifically Qlucore Omics Explorer, the vendor's data analysis platform for genomics and cancer research. Performance is at Bethesda, Maryland.</p>
<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $4,624.00 on March 13, 2018, with ultimate completion on April 13, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures scientific software licensing, specifically Qlucore Omics Explorer for data visualization and analysis in genomics and cancer research applications.</p>
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $24,000.00 Firm Fixed Price Delivery Order to Quantum Insights LLC, a minority-owned small disadvantaged business, to provide Common Operating Environment Tool Support and Maintenance services for a 6-month period of performance. The contract was awarded under the Multiple Award Schedule (MAS) contract vehicle. There was no set-aside used for this award. The delivery order has an ultimate completion date of September 30,...
<p>The National Cancer Institute awarded a purchase order to Qlucore Inc. for $23,596.00 on January 15, 2020, with final completion scheduled for February 17, 2020. No set-aside was used. Performance occurs in New York, New York. The order procures scientific software licensing, specifically Qlucore Omics Explorer with data analysis capabilities for research institutions. Pricing is firm fixed price.</p>
<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>
<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480 on June 9, 2020, with an ultimate completion date of June 14, 2021. Work is performed in Germantown, Maryland. The order is firm fixed price with no set-aside category. No additional source material specifies the scope of services or supplies procured under this purchase order.</p>
The National Cancer Institute issued a delivery order to Netimpact Strategies Inc., a woman-owned 8(a) small business, on June 30, 2021, under the GSA Multiple Award Schedule (MAS) for Portfolio Management Systems Support Services (PM3S), with a ceiling value of $4,417,954.56 and an ultimate completion date of June 29, 2026. Place of performance is Rockville, MD. The order is priced on a labor-hours basis with no set-aside designation. MRP LLC (trading as Itignite), an 8(a)-certified...